New Deal
Giovanni Caforio
Chairman and CEO at BRISTOL MYERS SQUIBB COMPANY
Manager
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (17)
Key Relationships
Announcement Date
Deal Value
Union De Pharmacologie Scientifique Appliquee
Taisho Pharmaceutical
£1,265m
21 dealmakers
Celgene Corporation
Bristol Myers Squibb Company
£70,659m
82 dealmakers
OTEZLA
Amgen
£10,900m
45 dealmakers
FORBIUS
value n/a
49 dealmakers
GRAIL
Illumina
£6,190m
107 dealmakers
MYOKARDIA
£10,012m
53 dealmakers
EXSCIENTIA
Novo Holdings
£49m
6 dealmakers
Ikena Oncology
Omega Funds
£88m
15 dealmakers
£71m
13 dealmakers
Pathai
Refactor Capital
£116m
18 dealmakers
Blade Therapeutics
Sprim Global Investment
£261m
16 dealmakers
METAGENOMI
MODERNA
£129m
17 dealmakers
Turning Point Therapeutics
£3,270m
56 dealmakers
Bighat Biosciences
Section 32 (s32)
£62m
Arsenal Biosciences
San Francisco Foundation Investment Company
£191m
14 dealmakers
Torl Biotherapeutics
£126m
Mirati Therapeutics
£3,840m
54 dealmakers